Together, we can turn groundbreaking concepts into impactful solutions.

Partnering with government, institutions, foundations, and nonprofits, we tackle pressing health challenges efficiently through the power of collaboration. Our experienced team of experts in science, medicine, engineering, and business work alongside our partners to identify and nurture high-potential health innovation projects. 

The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Moving Ideas Forward

  • Proven Processes: Streamlined methodologies that ensure efficiency and effectiveness. 
  • Hands-On Facilitation: Direct, personalized assistance at every step of the innovation process.
  • Global Network: Access to a world-class network of experts ready to lend insights and experience.
  • Customized Tools: Tailored infrastructure, tools, and resources designed to fit the needs of your project.  

     

Where We Excel

  • Spotting highly promising projects.
  • Engaging the world’s leading experts.
  • Minimizing risk through our Deep Dive evaluation.
  • Maximizing speed and efficiency with the support of tailored tools.
  • Accelerating development through our proven process.

 

 

Our Impact

We have supported more than 1,200 innovator teams, evaluated more than 5,000 ideas, and helped develop more than a thousand health innovations. Our efforts have resulted in:

  • 49% commercialization success rate.
  • $2 billion in follow-on funding.
  • 1000+ healthcare innovations developed.
  • touching millions of lives.

 

Innovation Spotlight

Innovation Spotlight

Blueprint MedTech Cycle 3 Announcement

Funding Opportunity: Blueprint MedTech Summer Award Competition

CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, are accepting pre-proposals from academic and industry applicants who have emerging preventative, therapeutic, or diagnostic medical devices focused on disorders of the nervous system. 

Awards up to $500K will be made available to the most promising and innovative neurotechnologies to help accelerate their development toward commercialization. 

A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space. 

Program Details: 

  • Awards up to $500K to help support development toward commercialization 

  • Mentorship from experienced MedTech commercialization experts 

  • Support to address business, regulatory, clinical, and technical project areas 

Pre-proposals are due no later than August 27th, 2023. 

Learn more or Apply >  
Register for an Informational Webinar >